
Boston Scientific Corporation (BSX)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
43.06 - Open
43.73 - Bid 44.90 x 20000
- Ask 44.91 x 100000
- Day's Range
43.45 - 45.80 - 52 Week Range
42.25 - 109.50 - Volume
16,076,174 - Avg. Volume
20,519,221 - Market Cap (intraday)
66.633B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
18.76 - EPS (TTM)
2.39 - Earnings Date Jul 29, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
75.00
Recent News
View MorePerformance Overview
Trailing total returns as of 7/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
64.00B
-
Enterprise Value
73.58B
-
Trailing P/E
18.02
-
Forward P/E
12.84
-
PEG Ratio (5yr expected)
0.52
-
Price/Sales (ttm)
3.12
-
Price/Book (mrq)
2.47
-
Enterprise Value/Revenue
3.57
-
Enterprise Value/EBITDA
13.39
Financial Highlights
Profitability and Income Statement
-
Profit Margin
17.29%
-
Return on Assets (ttm)
6.07%
-
Return on Equity (ttm)
14.66%
-
Revenue (ttm)
20.61B
-
Net Income Avi to Common (ttm)
3.56B
-
Diluted EPS (ttm)
2.39
Balance Sheet and Cash Flow
-
Total Cash (mrq)
1.45B
-
Total Debt/Equity (mrq)
42.25%
-
Levered Free Cash Flow (ttm)
2.81B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
Vickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional stock ownership trends. Form 13-Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters, and have now come in from 1Q26. We like to review the 13Fs of major activist investors -- including Carl Icahn, Trian Fund Management, Jana Partners, Starboard Value and ValueAct Holdings, among others -- in order to determine their core holdings and new purchases. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Activists have made progress in the past year, with high-profile investments into blue-chip companies such as Fedex and Union Pacific. Here are some recent new purchases and key holdings of activist investors, as well as other high-profile money managers.
Vickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional stock ownership trends. Form 13-Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters, and have now come in from 1Q26. We like to review the 13Fs of major activist investors -- including Carl Icahn, Trian Fund Management, Jana Partners, Starboard Value and ValueAct Holdings, among others -- in order to determine their core holdings and new purchases. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Activists have made progress in the past year, with high-profile investments into blue-chip companies such as Fedex and Union Pacific. Here are some recent new purchases and key holdings of activist investors, as well as other high-profile money managers.
-
Based in Marlborough, Massachusetts, Boston Scientific is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, oncology, endoscopy, urology, gynecology, and neuromodulation. The company is a component of the S&P 500.
Based in Marlborough, Massachusetts, Boston Scientific is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, oncology, endoscopy, urology, gynecology, and neuromodulation. The company is a component of the S&P 500.
RatingPrice Target -
This is one of the busiest weeks of the year on Wall Street. There's a Fed rate meeting, which is also the last meeting with current-but-departing Chairman Jerome Powell. As well, five of the Mag7 are due to report earnings and there's a lot of economic data coming out (including updated on GDP and inflation). Last week, the Dow Jones Industrial Average and the S&P 500 were essentially flat, while the Nasdaq gained 1.5%. Year to date, all three indices are in positive territory. The Dow is up 2%, the S&P 500 is higher by 5%, and the Nasdaq is up 7%. On the earnings calendar, about 850 public companies are reporting this week. Highlights include Verizon on Monday; Visa, Coca-Cola, Novartis, Seagate Technology, Starbucks, and UPS on Tuesday; Alphabet, Microsoft, Amazon, and Meta Platforms on Wednesday; Apple, Eli Lilly, Merck, and Caterpillar on Thursday; and Exxon Mobil and Chevron on Friday. Turning to the economic calendar, the Case-Shiller Home Price Index will be reported on Tuesday; the Federal Reserve rate decision comes on Wednesday (followed by a final press conference hosted by Chairman Powell); and the Personal Consumption Expenditures Index inflation indicator and an update on GDP hit the tape on Thursday. The impact of the war is showing up in economic forecasts. Gas prices have been elevated, but fell eight cents last week and are now at an average of $4.04 per gallon for regular gas. The Atlanta Fed GDPNow forecast is now calling for 1.2% growth in 1Q, down from 3.0% about a month ago. The Cleveland Fed Inflation Nowcast forecast is at 3.6% for CPI in April, up from the 3.3% print in March. Mortgage rates moved lower last week, down seven basis points, with the average 30-year fixed-rate mortgage at 6.23%, according to FreddieMac. For the Federal Open Market Committee (FOMC) meeting this week, odds are at zero for a rate move. President Trump's nominee to be the next Fed chairman, Kevin Warsh, testified before Congress last week as he continues to move through the formal approval process. Of note, the controversial DOJ investigation into Chairman Powell was dropped. His term as Chairman expires on May 15, though he will remain on the committee. Taking a deeper dive into year-to date performance, a leading industrialized global stock market index, the ETF EFA, is up 5% year to date, while the leading emerging market ETF (EEM) is up 16%. U.S. growth stocks are flat year to date when looking at ETF IWF, and value stocks (IWD) are up 7%. Crude oil has pulled back from its high of $110 on April 7. On Friday, it was at $94 per barrel, still up 62% for the year. In other asset classes for the year to date, AGG bonds are flat, gold is up 8%, and Bitcoin is down 11%. The U.S. dollar is flat, tracking DXY. The VIX Volatility Index was about 19 on Friday, below its historical average of 20. Turning to sector performance, the list from first to worst so far in 2026, as of March 31, is Energy (+27%), Materials (+14%), Industrials (+11%), Real Estate (+10%), Utilities (+9%), Consumer Staples (+9%), Information Technology (+8%), Communication Services (+5%), Consumer Discretionary (+2%), Financials (-5%), and Healthcare (-6%). By comparison, the S&P 500 is up 5% year to date.
This is one of the busiest weeks of the year on Wall Street. There's a Fed rate meeting, which is also the last meeting with current-but-departing Chairman Jerome Powell. As well, five of the Mag7 are due to report earnings and there's a lot of economic data coming out (including updated on GDP and inflation). Last week, the Dow Jones Industrial Average and the S&P 500 were essentially flat, while the Nasdaq gained 1.5%. Year to date, all three indices are in positive territory. The Dow is up 2%, the S&P 500 is higher by 5%, and the Nasdaq is up 7%. On the earnings calendar, about 850 public companies are reporting this week. Highlights include Verizon on Monday; Visa, Coca-Cola, Novartis, Seagate Technology, Starbucks, and UPS on Tuesday; Alphabet, Microsoft, Amazon, and Meta Platforms on Wednesday; Apple, Eli Lilly, Merck, and Caterpillar on Thursday; and Exxon Mobil and Chevron on Friday. Turning to the economic calendar, the Case-Shiller Home Price Index will be reported on Tuesday; the Federal Reserve rate decision comes on Wednesday (followed by a final press conference hosted by Chairman Powell); and the Personal Consumption Expenditures Index inflation indicator and an update on GDP hit the tape on Thursday. The impact of the war is showing up in economic forecasts. Gas prices have been elevated, but fell eight cents last week and are now at an average of $4.04 per gallon for regular gas. The Atlanta Fed GDPNow forecast is now calling for 1.2% growth in 1Q, down from 3.0% about a month ago. The Cleveland Fed Inflation Nowcast forecast is at 3.6% for CPI in April, up from the 3.3% print in March. Mortgage rates moved lower last week, down seven basis points, with the average 30-year fixed-rate mortgage at 6.23%, according to FreddieMac. For the Federal Open Market Committee (FOMC) meeting this week, odds are at zero for a rate move. President Trump's nominee to be the next Fed chairman, Kevin Warsh, testified before Congress last week as he continues to move through the formal approval process. Of note, the controversial DOJ investigation into Chairman Powell was dropped. His term as Chairman expires on May 15, though he will remain on the committee. Taking a deeper dive into year-to date performance, a leading industrialized global stock market index, the ETF EFA, is up 5% year to date, while the leading emerging market ETF (EEM) is up 16%. U.S. growth stocks are flat year to date when looking at ETF IWF, and value stocks (IWD) are up 7%. Crude oil has pulled back from its high of $110 on April 7. On Friday, it was at $94 per barrel, still up 62% for the year. In other asset classes for the year to date, AGG bonds are flat, gold is up 8%, and Bitcoin is down 11%. The U.S. dollar is flat, tracking DXY. The VIX Volatility Index was about 19 on Friday, below its historical average of 20. Turning to sector performance, the list from first to worst so far in 2026, as of March 31, is Energy (+27%), Materials (+14%), Industrials (+11%), Real Estate (+10%), Utilities (+9%), Consumer Staples (+9%), Information Technology (+8%), Communication Services (+5%), Consumer Discretionary (+2%), Financials (-5%), and Healthcare (-6%). By comparison, the S&P 500 is up 5% year to date.
-
Argus is hosting a five-part webinar series on AI. Our first webinar was on AI and IT, and our most-recent event was on AI and Healthcare. Still to come are webinars on AI and the Consumer Sectors (April 1); AI and Financial Services (May 6); and AI and Industrial/Energy (June 3). In our recent webinar, we noted that Healthcare companies are using AI to improve research, surgeries, drug development, best practices, and other health-related enhancements. During the webinar, we were asked which Healthcare companies have strong records of innovation and are embracing breakthroughs in AI - and the following is a list of those companies, as we see it. They are all rated BUY at Argus.
Argus is hosting a five-part webinar series on AI. Our first webinar was on AI and IT, and our most-recent event was on AI and Healthcare. Still to come are webinars on AI and the Consumer Sectors (April 1); AI and Financial Services (May 6); and AI and Industrial/Energy (June 3). In our recent webinar, we noted that Healthcare companies are using AI to improve research, surgeries, drug development, best practices, and other health-related enhancements. During the webinar, we were asked which Healthcare companies have strong records of innovation and are embracing breakthroughs in AI - and the following is a list of those companies, as we see it. They are all rated BUY at Argus.








